• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Anoctamin-3 (ANO3), Truncated

ACP05754

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP05754 Target NameANO3
Target SynonymsANO3; C11orf25; TMEM16C; GENX-3947Anoctamin-3; Transmembrane protein 16CFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Protein LengthPartial
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9BYT9
Background Information
  • Uniprot Id

    Q9BYT9

  • Target Species

    Human

  • Target Name

    ANO3

  • Target Full Name

    Anoctamin-3

  • Target Function

    Has calcium-dependent phospholipid scramblase activity; scrambles phosphatidylcholine and galactosylceramide. Seems to act as potassium channel regulator and may inhibit pain signaling; can facilitate KCNT1/Slack channel activity by promoting its full single-channel conductance at very low sodium concentrations and by increasing its sodium sensitivity. Does not exhibit calcium-activated chloride channel (CaCC) activity.

  • Target Involvement

    Dystonia 24 (DYT24)

  • Target Subcellular Location

    Cell membrane; Multi-pass membrane protein.

  • Target Protein Families

    Anoctamin family

  • Target Tissue Specificity

    Highly expressed in the forebrain striatum.

  • Target Synonyms

    ANO3; C11orf25; TMEM16C; GENX-3947Anoctamin-3; Transmembrane protein 16C

Inquire Recombinant Human Anoctamin-3 (ANO3), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification